All In MedTech

Device Trial Radar · NCT06228274

Assessment of Safety and Efficacy of ARTHRUM 2.5% for Treatment of Painful Osteoarthritis of the Knee

Measurement of the Real Life Efficacy of ARTHRUM 2.5% Health Product Single Injection in Patients Suffering From Knee Osteoarthritis

Last checked: Nov 20, 2026Latest source record: Jan 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

218

Actual

Start

Mar 2013

Primary completion

Sep 2015

Study completion Mar 2017

Sponsor

Lead sponsor
LCA PharmaceuticalNot on our public-company list
Sponsor type
Industry
Collaborators
BIOSTATEM
First posted
Jan 29, 2024

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

ARTHRUM 2.5% MONO-INJECTION as symptomatic treatment by joint injection extends the conservative therapeutic arsenal in Knee osteoarthritis. The reduction of functional limits and disabilities induced by knee osteoarthritis as well as improvement of quality of life of patients is a public health need registered amongst the priorities established by the French law of 9 August 2004 relative to Public Health policy. However, the response to this need is not limited to treatment with health products. This prospective, open, multi-centre trial of the real-life efficacy of ARTHRUM 2.5% aims to demonstrate the efficacy of a single joint injection of this treatment on pain, during 6 months, in the symptomatic treatment of patients suffering from Knee osteoarthritis

Conditions

  • Knee Osteoarthritis

Interventions

  • ARTHRUM 2.5%Device

    ARTHRUM 2.5%

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of ARTHRUM 2.5% single joint injection on pain assessed by Likert scale on five levelsTime frame: 6 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.